What Is the Use of Ozempic Injection? A Comprehensive Guide

Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections have become a transformative tool in weight management, helping patients reduce body weight by an average of 15–22% over 68 weeks in clinical trials. This medication works by mimicking glucagon-like peptide-1 (GLP-1), a natural hormone that controls appetite and blood sugar regulation. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies, making personalized weight loss therapy accessible nationwide without insurance requirements.

How Semaglutide Injections Work for Weight Management

Semaglutide injections function as a GLP-1 receptor agonist, meaning they bind to and activate GLP-1 receptors throughout the body. These receptors sit in appetite-regulating regions of the brain, particularly the hypothalamus, where they suppress hunger signals and increase feelings of fullness. The medication also slows gastric emptying—the rate at which food moves from the stomach—extending satiety and reducing overall calorie intake naturally.

Beyond appetite control, semaglutide influences glucose homeostasis by stimulating insulin secretion when blood sugar rises. This dual action supports metabolic health and helps stabilize energy levels throughout the day. Patients typically experience reduced cravings for high-calorie foods and improved adherence to calorie-deficit nutrition plans, creating conditions for sustainable weight loss rather than temporary restriction.

Clinical Evidence: Semaglutide Injection Efficacy in Trials

The STEP program, a series of randomized controlled trials spanning over 68 weeks, demonstrated that participants receiving semaglutide 2.4 mg weekly achieved mean weight reductions of 17.4% from baseline, compared to 2.4% in the placebo group. Notably, 86% of patients on semaglutide reached at least 5% weight loss—a threshold associated with meaningful health improvements including blood pressure reduction and improved lipid profiles. These results represent one of the most robust pharmacologic weight-loss interventions available in modern medicine.

Secondary outcomes in these trials revealed improvements in cardiometabolic markers: fasting glucose declined significantly, HbA1c levels dropped in participants with elevated baseline values, and waist circumference reduced independently of total body weight loss. Safety monitoring across the trials showed that gastrointestinal side effects, while common early on, were generally mild to moderate and often diminished as patients adjusted to the medication over weeks.

Primary Medical Uses Beyond Weight Loss

While weight management is the most common use, semaglutide was originally developed and FDA-approved for type 2 diabetes management. At lower doses (0.5–1.0 mg weekly), it improves glycemic control by enhancing pancreatic beta-cell function and reducing hepatic glucose production. Patients with prediabetes or metabolic syndrome often benefit from semaglutide's glucose-stabilizing effects, which can delay or prevent progression to overt diabetes.

Emerging research suggests additional cardiovascular benefits: the SUSTAIN-6 trial found that semaglutide reduced major adverse cardiovascular events by 26% in high-risk diabetic patients. This cardioprotective effect appears independent of weight loss alone, indicating that GLP-1 activation may directly benefit heart and blood vessel health through anti-inflammatory and endothelial-protective mechanisms.

Getting Started with Semaglutide: PlexusDx Personalized Approach

PlexusDx makes semaglutide therapy accessible through compounded injections from licensed 503A pharmacies, at $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance requirement. Patients in all 50 states can begin with an initial consultation to assess medical history, current medications, and weight-loss goals. The platform supports HSA and FSA payment options, reducing out-of-pocket costs for eligible users.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical starting dose of semaglutide for weight loss?

The standard protocol begins at 0.25 mg weekly, increasing by 0.25 mg each week until reaching the target dose of 2.4 mg weekly. This gradual titration minimizes gastrointestinal side effects and allows the body to adapt. PlexusDx supports flexible dosing schedules, and pricing remains flat at $189 per month regardless of dose level.

How long does semaglutide take to show weight loss results?

Most patients notice reduced appetite within the first 1–2 weeks, though measurable weight loss typically appears after 4–6 weeks of consistent use. Maximal effects emerge around 16–20 weeks as the dose reaches therapeutic levels and lifestyle adjustments compound. Clinical trials showed sustained weight loss continued through 68 weeks, suggesting benefits are durable with ongoing treatment.

Can I use semaglutide if I have type 2 diabetes?

Yes—semaglutide was originally approved for diabetes and offers dual benefits: improved blood sugar control and weight loss. However, combining semaglutide with other diabetes medications may increase hypoglycemia risk, requiring dose adjustments to other agents. PlexusDx providers review all medications during consultation to ensure safe, coordinated therapy.

What are the most common side effects of semaglutide injections?

Gastrointestinal effects—nausea, vomiting, diarrhea, and constipation—occur in 25–40% of users, most often during the first 2–4 weeks. These are typically mild to moderate and diminish over time as the body adjusts. Serious side effects are rare; pancreatitis, gallbladder issues, and thyroid concerns require immediate medical attention and warrant stopping the medication.

How does the Precision Peptide Genetic Test help personalize my semaglutide therapy?

PlexusDx's Precision Peptide Genetic Test identifies your genetic predispositions across GLP-1 signaling, appetite regulation (FTO and MC4R pathways), and glucose metabolism. Patients with favorable GLP1R variants often respond robustly to semaglutide, while those with specific FTO variants may benefit from additional lifestyle support. The test is $298 and informs PlexusDx whether semaglutide alone or combination therapy (like GLP-Squared) optimizes your outcome.

Related Reading

• Injection Ozempic
• Injection Sites For Ozempic
• Ozempic Injection Sites
• Ozempic Injection

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.